New Enterprise Ventures is a consulting firm specializing in delivering transformative strategy and business development to accelerate penetration in the US healthcare market. We are uniquely positioned to guide early-stage companies and industry leaders to make better-informed business decisions that require both technical insight and unsurpassed access to cutting-edge technologies and economic buyers.
We offer end-to-end integrated services including strategy, business development, and executive placement. Our extensive experience and pedigree in the healthcare marketplace provide us with unique insight into aligning corporate strategy with execution, including navigating the burgeoning world of data and analytics, making more informed buy, build and license decisions on emerging technologies, and delivering strategic partners that drive sales and revenue.
Our advisory board is composed of premiere professionals representing critical areas across the healthcare continuum.
Learn more about the expertise each of our board members can bring to our clients.
Who will be the DPHARM Idol Disrupt 2022 winner? Donna Usiskin, NEV Chief Strategy Officer along with an elite group industry experts will be providing the questions and judging the answers at the upcoming 2022 DPharm conference.
Boehringer Ingelheim Pharmaceuticals Inc. and HealthPrize announced statistically significant results from a retrospective observational study that showed 44% greater medication adherence for patients that self-enrolled in the RespiPoints program, compared to matched patients not enrolled in the program.
Maryland physicians have access to an exclusive platform for open discussion of patient cases and knowledge sharing thanks to collaboration between MedChi, The Maryland State Medical Society, and Figure 1, a dynamic medical app for physicians and healthcare professionals.
Glooko, Inc., a leading provider of remote patient monitoring and digital health solutions announced a collaboration with Johns Hopkins HealthCare Solutions. Glooko’s cloud-based, device-agnostic platform and patient app will provide vitals capture and tracking enablement to the Johns Hopkins Blossom™ program, an interactive management program for people with diabetes, offered through employers, health plans and health care providers.
Who will be the DPHARM Idol Disrupt 2022 winner? Donna Usiskin, NEV Chief Strategy Officer along with an elite group industry experts will be providing the questions and judging the answers at the upcoming 2022 DPharm conference.
Boehringer Ingelheim Pharmaceuticals Inc. and HealthPrize announced statistically significant results from a retrospective observational study that showed 44% greater medication adherence for patients that self-enrolled in the RespiPoints program, compared to matched patients not enrolled in the program.
Maryland physicians have access to an exclusive platform for open discussion of patient cases and knowledge sharing thanks to collaboration between MedChi, The Maryland State Medical Society, and Figure 1, a dynamic medical app for physicians and healthcare professionals.
